Viruses and type 1 diabetes: A new look at an old story

Pediatric Diabetes

Volumn 14, Issue 3, 2013, Pages 149-158

  Craig, Maria E ^a,b,c   Nair, Sandhya ^d   Stein, Hayley ^a   Rawlinson, William D ^d,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

cell; Apoptosis; Coxsackievirus; Cytokine; Cytomegalovirus; Enterovirus; Epidemiology; Pathogenesis; Rotavirus; Type 1 diabetes; Viral infection

Indexed keywords

CHILD; DEATH; DENMARK; ENTEROVIRUS; EPIDEMIC; FRANCE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NORWAY; PAROTITIS; PRIORITY JOURNAL; REVIEW; SEROLOGY; SEROTYPE; TAXONOMY; UNITED STATES; VIRUS INFECTION;

ANIMALS; APOPTOSIS; DEAD-BOX RNA HELICASES; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; ISLETS OF LANGERHANS; VIRUS DISEASES;

EID: 84876804581     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12033     Document Type: Review

References (110)

1. Gundersen E. Is diabetes of infectious origin? J Infect Dis 1927: 41: 197-202.
2. Catanzariti L, Faulks K, Moon L, Waters AM, Flack J, Craig ME. Australia's national trends in the incidence of Type 1 diabetes in 0-14-year-olds, 2000-2006. Diabet Med 2009: 26: 596-601.
3. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009: 373: 2027-2033.
4. Gillespie KM, Bain SC, Barnett AH et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 2004: 364: 1699-1700.
5. Fourlanos S, Varney MD, Tait BD et al. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 2008: 31: 1546-1549.
6. Podar T, LaPorte RE, Tuomilehto J, Shubnikov E. Risk of childhood type 1 diabetes for Russians in Estonia and Siberia. Int J Epidemiol 1993: 22: 262-267.
7. Bruno G, Merletti F, Pagano G. Incidence of insulin-dependent diabetes among Sardinian migrants to northern Italy. Lancet 1996: 347: 193.
8. Patterson CC, Thorogood M, Smith PG, Heasman MA, Clarke JA, Mann JI. Epidemiology of type 1 (insulin-dependent) diabetes in Scotland 1968-1976: evidence of an increasing incidence. Diabetologia 1983: 24: 238-243.
9. Samuelsson U, Johansson C, Carstensen J, Ludvigsson J. Space-time clustering in insulin-dependent diabetes mellitus (IDDM) in south-east Sweden. Int J Epidemiol 1994: 23: 138-142.
10. Dahlquist GG, Kallen BA. Time-space clustering of date at birth in childhood-onset diabetes. Diabetes Care 1996: 19: 328-332.
11. Samuelsson U, Carstensen J. Space-time clustering at birth and at diagnosis of type 1 diabetes mellitus in relation to early clinical manifestation. J Pediatr Endocrinol Metab. 2003: 16: 859-867.
12. Adams SF. The seasonal variation in the onset of acute diabetes: the age and sex factors in 1000 patients. Arch Intern Med 1926: 37: 861-864.
13. Gamble DR, Taylor KW. Seasonal incidence of diabetes mellitus. Bmj 1969: 3: 631-633.
14. Bloom A, Hayes TM, Gamble DR. Register of newly diagnosed diabetic children. BMJ 1975: 3: 580-583.
15. Christau B, Kromann H, Christy M, Andersen OO, Nerup J. Incidence of insulin-dependent diabetes mellitus (0-29years at onset) in Denmark. Acta Med Scand Suppl 1979: 624: 54-60.
16. Gleason RE, Kahn CB, Funk IB, Craighead JE. Seasonal incidence of insulin-dependent diabetes (IDDM) in Massachusetts, 1964-1973. Int J Epidemiol 1982: 11: 39-45.
17. Allen C, Palta M, D'Alessio DJ. Incidence and differences in urban-rural seasonal variation of type 1 (insulin-dependent) diabetes in Wisconsin. Diabetologia 1986: 29: 629-633.
18. Rewers M, Stone RA, LaPorte RE et al. Poisson regression modeling of temporal variation in incidence of childhood insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania, and Wielkopolska, Poland, 1970-1985. American Journal of Epidemiology 1989: 129: 569-581.
19. Craig ME, Howard NJ, Silink M, Chan A. The rising incidence of childhood type 1 diabetes in New South Wales, Australia. J Pediatr Endocrinol Metab 2000: 13: 363-372.
20. WDPGo Epidemics. Childhood diabetes, epidemics, and epidemiology: an approach for controlling diabetes. Am J Epidemiol 1992: 135: 803-816.
21. Wagenknecht LE, Roseman JM, Herman WH. Increased incidence of insulin-dependent diabetes mellitus following an epidemic of Coxsackievirus B5. Am J Epidemiol 1991: 133: 1024-31.
22. Khakpour M, Nik-Akhtar B. Diabetes mellitus following a mumps epidemic. J Trop Med Hyg 1975: 78: 262-263.
23. Hyoty H, Leinikki P, Reunanen A et al. Mumps infections in the etiology of type 1 (insulin-dependent) diabetes. Diabetes Res 1988: 9: 111-116.
24. Ramondetti F, Sacco S, Comelli M et al. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry. Diabet Med 2012: 29: 761-766.
25. Burgess MA, Forrest JM. Congenital rubella and diabetes mellitus. Diabetologia 2009: 52: 369-370; author reply 73.
26. Pak CY, Eun HM, McArthur RG, Yoon JW. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 1988: 2: 1-4.
27. Honeyman MC, Coulson BS, Stone NL, Gellert SA, Goldwater PN et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000: 49: 1319-1324.
28. van der Werf N, Hillebrands JL, Klatter FA, Bos I, Bruggeman CA, Rozing J. Cytomegalovirus infection modulates cellular immunity in an experimental model for autoimmune diabetes. Clin Dev Immunol 2003: 10: 153-160.
29. Graham KL, Sanders N, Tan Y, Allison J, Kay TW, Coulson BS. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol 2008: 82: 6139-6149.
30. Gamble DR, Kinsley ML, FitzGerald MG, Bolton R, Taylor KW. Viral antibodies in diabetes mellitus. Bmj 1969: 3: 627-630.
31. King ML, Shaikh A, Bidwell D, Voller A, Banatvala JE. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet 1983: 1: 1397-1399.
32. Banatvala JE, Bryant J, Schernthaner G et al. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1985: 1: 1409-1412.
33. D'Alessio DJ. A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 1992: 135: 1331-1338.
34. Hyoty H, Hiltunen M, Knip M et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 1995: 44: 652-657.
35. Dippe SE, Bennett PH, Miller M, Maynard JE, Berquist KR. Lack of causal association between Coxsackie B4 virus infection and diabetes. Lancet 1975: 1: 1314-1317.
36. Richens ER, Jones GW, Betterle C et al. Viruses and diabetes of recent onset. Lancet 1983: 2: 345.
37. Orchard TJ, Atchison RW, Becker D et al. Coxsackie infection and diabetes. Lancet 1983: 2: 631.
38. Tuvemo T, Dahlquist G, Frisk G et al. The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children-no evidence of increased antibody frequency. Diabetologia 1989: 32: 745-747.
39. Green J, Casabonne D, Newton R. Coxsackie B virus serology and Type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med 2004: 21: 507-514.
40. Craig ME, Robertson P, Howard NJ, Silink M, Rawlinson WD. Diagnosis of enterovirus infection by genus-specific PCR and enzyme-linked immunosorbent assays. J Clin Microbiol 2003: 41: 841-844.
41. Hyoty H, Huupponen T, Leinikki P. Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus. Clin Exp Immunol 1985: 60: 139-144.
42. Ward KP, Galloway WH, Auchterlonie IA. Congenital cytomegalovirus infection and diabetes. Lancet 1979: 1: 497.
43. Toniolo A, Conaldi PG, Garzelli C et al. Role of antecedent mumps and reovirus infections on the development of type 1 (insulin-dependent) diabetes. Eur J Epidemiol 1985: 1: 172-179.
44. Blomqvist M, Juhela S, Erkkila S et al. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2years of life. Clin Exp Immunol 2002: 128: 511-515.
45. Craig ME, Howard NJ, Silink M, Rawlinson WD. Reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes associated with enterovirus RNA. J Infect Dis 2003: 187: 1562-1570.
46. Krause I, Anaya JM, Fraser A et al. Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci 2009: 1173: 633-639.
47. Clements GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995: 346: 221-223.
48. Stene LC, Oikarinen S, Hyoty H et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010: 59: 3174-3180.
49. Oikarinen S, Martiskainen M, Tauriainen S et al. Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 2011: 60: 276-279.
50. Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979: 300: 1173-1179.
51. Dotta F, Censini S, van Halteren AG et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007: 104: 5115-5120.
52. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009: 52: 1143-1151.
53. Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 2013: 56: 185-193.
54. Oikarinen M, Tauriainen S, Oikarinen S et al. Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes 2012: 61: 687-691.
55. Mercalli A, Lampasona V, Klingel K et al. No evidence of enteroviruses in the intestine of patients with type 1 diabetes. Diabetologia 2012: 55: 2479-2488.
56. Cinek O, Witso E, Jeansson S et al. Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes. J Clin Virol 2006: 35: 33-40.
57. Simonen-Tikka ML, Pflueger M, Klemola P et al. Human enterovirus infections in children at increased risk for type 1 diabetes: the Babydiet study. Diabetologia 2011: 54: 2995-3002.
58. Craighead JE, McLane MF. Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 1968: 162: 913-914.
59. Tracy S, Drescher KM, Jackson JD, Kim K, Kono K. Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Rev Med Virol 2010: 20: 106-116.
60. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000: 49: 708-711.
61. Serreze DV, Wasserfall C, Ottendorfer EW et al. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 2005: 79: 1045-1052.
62. Diana J, Brezar V, Beaudoin L et al. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J Exp Med 2011: 208: 729-745.
63. Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 2004: 329: 381-394.
64. Bae YS, Eun HM, Yoon JW. Genomic differences between the diabetogenic and nondiabetogenic variants of encephalomyocarditis virus. Virology 1989: 170: 282-287.
65. Halim S, Ramsingh AI. A point mutation in VP1 of coxsackievirus B4 alters antigenicity. Virology 2000: 269: 86-94.
66. von Herrath M, Nepom GT. Animal models of human type 1 diabetes. Nat Immunol 2009: 10: 129-132.
67. Nair S, Leung KC, Rawlinson WD, Naing Z, Craig ME. Enterovirus infection induces cytokine and chemokine expression in insulin-producing cells. J Med Virol 2010: 82: 1950-1957.
68. Ylipaasto P, Klingel K, Lindberg AM et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004: 47: 225-239.
69. Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 2002: 45: 693-702.
70. Chehadeh W, Kerr-Conte J, Pattou F et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 2000: 74: 10153-10164.
71. Elshebani A, Olsson A, Westman J, Tuvemo T, Korsgren O, Frisk G. Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes. Virus Res 2007: 124: 193-203.
72. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by coxsackie virus - initiation by bystander damage and not molecular mimicry. Nat Med 1998: 4: 781-785.
73. Honeyman MC, Stone NL, Falk BA, Nepom G, Harrison LC. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol 2010: 184: 2204-2210.
74. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009: 5: 219-226.
75. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009: 155: 173-181.
76. Frigerio S, Junt T, Lu B et al. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 2002: 8: 1414-1420.
77. Roivainen M, Rasilainen S, Ylipaasto P et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 2000: 85: 432-440.
78. Stechova K, Bohmova K, Vrabelova Z et al. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes. Diabetes Metab Res Rev 2007: 23: 462-471.
79. Yeung WC, Al-Shabeeb A, Pang CN et al. Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile. Diabetes 2012: 61: 1500-1508.
80. Chatzigeorgiou A, Harokopos V, Mylona-Karagianni C, Tsouvalas E, Aidinis V, Kamper EF. The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Ann Med 2010: 42: 426-438.
81. Skarsvik S, Puranen J, Honkanen J, et al. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes. Diabetes 2006: 55: 996-1003.
82. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011: 342: d35.
83. Nairn C, Galbraith DN, Taylor KW, Clements GB. Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabet Med 1999: 16: 509-513.
84. Yin H, Berg AK, Tuvemo T, Frisk G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 2002: 51: 1964-1971.
85. Salminen K, Sadeharju K, Lonnrot M et al. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003: 69: 91-98.
86. Schulte BM, Bakkers J, Lanke KH et al. Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. Viral Immunol 2010: 23: 99-104.
87. Kang Y, Chatterjee NK, Nodwell MJ, Yoon JW. Complete nucleotide sequence of a strain of coxsackie B4 virus of human origin that induces diabetes in mice and its comparison with nondiabetogenic coxsackie B4 JBV strain. J Med Virol 1994: 44: 353-361.
88. Jun HS, Kang Y, Yoon HS, Kim KH, Notkins AL, Yoon JW. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes 1998: 47: 576-582.
89. Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010: 6: 279-289.
90. Howson JM, Cooper JD, Smyth DJ et al. Evidence of Gene-Gene Interaction and Age-at-Diagnosis Effects in Type 1 Diabetes. Diabetes 2012: 61: 3012-3017.
91. Cooper JD, Howson JM, Smyth D et al. Confirmation of novel type 1 diabetes risk loci in families. Diabetologia 2012: 55: 996-1000.
92. Crampton SP, Deane JA, Feigenbaum L, Bolland S. IFIH1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol 2012: 188: 1451-1459.
93. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010: 79: 351-379.
94. Fernandez-Valverde SL, Taft RJ, Mattick JS. MicroRNAs in beta-cell biology, insulin resistance, diabetes and its complications. Diabetes 2011: 60: 1825-1831.
95. Ruan Q, Wang T, Kameswaran V et al. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci U S A 2011: 108: 12030-12035.
96. Hober D, Sane F. Enteroviral pathogenesis of type 1 diabetes. Discov Med 2010: 10: 151-160.
97. Roivainen M, Knip M, Hyoty H et al. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 1998: 56: 74-78.
98. King ML, Bidwell D, Voller A, Bryant J, Banatvala JE. Role of Coxsackie B viruses in insulin-dependent diabetes mellitus. Lancet 1983: 2: 915-916.
99. Andreoletti L, Hober D, Hober-Vandenberghe C et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol 1997: 52: 121-127.
100. Champsaur H, Dussaix E, Samolyk D, Fabre M, Bach C, Assan R. Diabetes and Coxsackie virus B5 infection [letter]. Lancet 1980: 1: 251.
101. Hindersson M, Elshebani A, Orn A, Tuvemo T, Frisk G. Simultaneous type 1 diabetes onset in mother and son coincident with an enteroviral infection. J Clin Virol 2005: 33: 158-167.
102. Williams CH, Oikarinen S, Tauriainen S, Salminen K, Hyoty H, Stanway G. Molecular analysis of an echovirus 3 strain isolated from an individual concurrently with appearance of islet cell and IA-2 autoantibodies. J Clin Microbiol 2006: 44: 441-448.
103. Diaz-Horta O, Bello M, Cabrera-Rode E et al. Echovirus 4 and type 1 diabetes mellitus. Autoimmunity 2001: 34: 275-281.
104. Smith CP, Clements GB, Riding MH, Collins P, Bottazzo GF, Taylor KW. Simultaneous onset of type 1 diabetes mellitus in identical infant twins with enterovirus infection. Diabet Med 1998: 15: 515-517.
105. Otonkoski T, Roivainen M, Vaarala O et al. Neonatal Type I diabetes associated with maternal echovirus 6 infection: a case report. Diabetologia 2000: 43: 1235-1238.
106. Vreugdenhil GR, Schloot NC, Hoorens A et al. Acute onset of type i diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways. Clin Infect Dis 2000: 31: 1025-1031.
107. Paananen A, Ylipaasto P, Rieder E, Hovi T, Galama J, Roivainen M. Molecular and biological analysis of echovirus 9 strain isolated from a diabetic child. J Med Virol 2003: 69: 529-537.
108. Cabrera-Rode E, Sarmiento L, Tiberti C et al. Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16. Diabetologia 2003: 46: 1348-1353.
109. Cabrera-Rode E, Sarmiento L, Molina G et al. Islet cell related antibodies and type 1 diabetes associated with echovirus 30 epidemic: a case report. J Med Virol 2005: 76: 373-377.
110. Paananen A, Savolainen-Kopra C, Kaijalainen S, Vaarala O, Hovi T, Roivainen M. Genetic and phenotypic diversity of echovirus 30 strains and pathogenesis of type 1 diabetes. J Med Virol 2007: 79: 945-955.